This is a follow-up to the last in-person meeting, where we discussed the implementation of biosimilars to improve the uptake of more cost-effective drugs in healthcare systems.

We would therefore like to invite you to share your thoughts on the matter and contribute to the preparation of the next meeting in Vienna in 2026.

We kindly ask you to share some of your ideas and knowledge with us through this survey and the virtual meeting. Please use the following survey to document everything and the virtual meeting to clarify any topics if needed. Please check the documents offered, including the results from previous meetings.

The results of the surveys and the discussions around them will be published, and you will have the opportunity to review the summary.

Step 1: Round 1 survey and virtual meeting

You will complete an online questionnaire covering the following four domains: governance structures; financing flows; cultural acceptance and trust; and distributional context. The rating takes approximately 15–20 minutes. In addition, there will be a regional virtual conference to clarify topics and discuss questions. All responses are anonymous. Contact information will be used to get in touch with you again.

Step 2: Tools and implementation of global knowledge – Round 2 survey

Using the results of Round 1, we will assess the suitability of our proposed tools for your request for global support and identify the tool you are using to implement this in your national settings. You will receive a summary of the aggregated Round 1 results. These results will also help you identify potential partners in your region for the implementation of more cost-effective drugs (upon request to the Secretariat and with the permission of those involved).

The data from the two surveys will be used at the annual meeting in Vienna, where it will be discussed and analysed in a workshop. It will also be used for a publication on global knowledge transfer and national implementation requirements. Based on the results, we will also consider publishing on specific regional issues if they differ from global approaches. This will be decided based on the results in Vienna. If you are participating in the Vienna meeting or are interested in joining the publication group independently, please indicate this in both surveys.

Step 3: Global in-person workshop

Representatives from all three regions will meet at a workshop in Vienna to compile the regional findings and translate them into actions that support implementation. How can global knowledge be incorporated into national actions in the most efficient way? What knowledge is needed within a system, and what can be adapted from other systems? Based on 30 years of experience in horizon scanning and technology awareness, we would like to describe adaptation pathways.

Final tools and recommendation synthesis publication

The combined insights from all regions and the workshop will be synthesised into a final publication on global learnings and actionable recommendations for implementation-supportive frameworks, which will be published in a high-level, public health-oriented journal.

If you have received this as a request by somebody else, please keep in mind that the survey is addressing experts with professional experience in health policy, HTA, reimbursement, procurement, clinical practice, pharmacy, regulatory affairs, implementation science, or biosimilars — working in or with the LATAM, Gulf/EMRO, or ASEAN region.

All survey responses will be processed and analysed anonymously at an aggregate level. If you would like to share your knowledge with other colleagues and agree to be contacted, please select the opt-in option. In this case, your personal information will be collected separately from the survey questions.

Wherever possible, contact information should be collected separately from survey responses in case follow-up contact is required for a subsequent Delphi round. This helps to preserve confidentiality while maintaining continuity across rounds.

This study is conducted as a project of i-HTScience and I2GG.

i‑HTScience
i‑HTScience is the scientific and methodological platform of EuroScan/i-HTS. It engages members and partner organisations of EuroScan/i-HTS in scientific projects.

I2GG
I2GG is a research institute of applied science for strategic health analysis with a focus on health technology assessment, implementation questions and life‑cycle–oriented evaluation of health technologies. I2GG is member of EuroScan/i-HTS (i2gg.de).

Why does this study focus on implementation?
Because the practical uptake of biosimilars is shaped not only by evidence and regulation, but also by organisational, financial, behavioural, and system-level conditions.

Will there be more than one survey round?
Modified Delphi studies commonly include at least two rounds in order to provide feedback and reassessment. The final agreementw will be done within a workshop.

How long will participation take?
Completion time for the first-round survey is expected to be approximately 15 to 20 minutes.

Will responses remain confidential?
Responses will be analysed in anonymised or de-identified and aggregated form, and no individual response will be attributed without explicit consent.